Is dialysis water a safe component for hemodialysis treatment in São Paulo State, Brazil?
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Pharmaceutical Sciences |
Texto Completo: | https://www.revistas.usp.br/bjps/article/view/181572 |
Resumo: | Failure on the water treatment poses hemodialysis patients at risk of injury and death. Identifying if the patients are exposed to water quality related microbiological risks is an important objective to reduce the mortality for chronic renal patients and is the main issue of this study. We evaluated the microbiological water quality used by 205 dialysis services in São Paulo State, Brazil between 2010 to 2016. The study included heterotrophic bacteria count, total coliforms research, and bacterial endotoxin determination in 1366 dialysis water samples. The number of unsatisfactory clinics for at least one microbiological parameter decreased 16.0% between 2010 to 2015 but increased 57.2% in 2016. In 2010, the most frequent unsatisfactory parameter was related to heterotrophic bacteria count (54.8%) followed by endotoxin determination (45.2%). However, in 2013 an opposite situation was observed: endotoxin determination as the parameter of the higher incidence of nonconformities. Total coliform was verified at a lower frequency. We highlighted the importance of regular monitoring of dialysis water quality to prevent infections caused by dialytic procedures and to ensure that the water is a safe component of the treatment. |
id |
USP-31_947f0b49ffb38093733e4b6a83cf6969 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/181572 |
network_acronym_str |
USP-31 |
network_name_str |
Brazilian Journal of Pharmaceutical Sciences |
repository_id_str |
|
spelling |
Is dialysis water a safe component for hemodialysis treatment in São Paulo State, Brazil?Hemodialysis waterEndotoxinMicrobiological water qualityHemodialysisFailure on the water treatment poses hemodialysis patients at risk of injury and death. Identifying if the patients are exposed to water quality related microbiological risks is an important objective to reduce the mortality for chronic renal patients and is the main issue of this study. We evaluated the microbiological water quality used by 205 dialysis services in São Paulo State, Brazil between 2010 to 2016. The study included heterotrophic bacteria count, total coliforms research, and bacterial endotoxin determination in 1366 dialysis water samples. The number of unsatisfactory clinics for at least one microbiological parameter decreased 16.0% between 2010 to 2015 but increased 57.2% in 2016. In 2010, the most frequent unsatisfactory parameter was related to heterotrophic bacteria count (54.8%) followed by endotoxin determination (45.2%). However, in 2013 an opposite situation was observed: endotoxin determination as the parameter of the higher incidence of nonconformities. Total coliform was verified at a lower frequency. We highlighted the importance of regular monitoring of dialysis water quality to prevent infections caused by dialytic procedures and to ensure that the water is a safe component of the treatment.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2020-12-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/18157210.1590/s2175-97902019000417835Brazilian Journal of Pharmaceutical Sciences; Vol. 56 (2020); e17835Brazilian Journal of Pharmaceutical Sciences; v. 56 (2020); e17835Brazilian Journal of Pharmaceutical Sciences; Vol. 56 (2020); e178352175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/181572/168564Copyright (c) 2020 Brazilian Journal of Pharmaceutical Scienceshttp://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessHilinski, Ellen Gameiro Almodovar, Adriana Aparecida BuzzoSilva, Fernando Pontes de Lima e Pinto, Terezinha de Jesus Andreoli Bugno, Adriana 2021-06-12T19:46:54Zoai:revistas.usp.br:article/181572Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2021-06-12T19:46:54Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Is dialysis water a safe component for hemodialysis treatment in São Paulo State, Brazil? |
title |
Is dialysis water a safe component for hemodialysis treatment in São Paulo State, Brazil? |
spellingShingle |
Is dialysis water a safe component for hemodialysis treatment in São Paulo State, Brazil? Hilinski, Ellen Gameiro Hemodialysis water Endotoxin Microbiological water quality Hemodialysis |
title_short |
Is dialysis water a safe component for hemodialysis treatment in São Paulo State, Brazil? |
title_full |
Is dialysis water a safe component for hemodialysis treatment in São Paulo State, Brazil? |
title_fullStr |
Is dialysis water a safe component for hemodialysis treatment in São Paulo State, Brazil? |
title_full_unstemmed |
Is dialysis water a safe component for hemodialysis treatment in São Paulo State, Brazil? |
title_sort |
Is dialysis water a safe component for hemodialysis treatment in São Paulo State, Brazil? |
author |
Hilinski, Ellen Gameiro |
author_facet |
Hilinski, Ellen Gameiro Almodovar, Adriana Aparecida Buzzo Silva, Fernando Pontes de Lima e Pinto, Terezinha de Jesus Andreoli Bugno, Adriana |
author_role |
author |
author2 |
Almodovar, Adriana Aparecida Buzzo Silva, Fernando Pontes de Lima e Pinto, Terezinha de Jesus Andreoli Bugno, Adriana |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Hilinski, Ellen Gameiro Almodovar, Adriana Aparecida Buzzo Silva, Fernando Pontes de Lima e Pinto, Terezinha de Jesus Andreoli Bugno, Adriana |
dc.subject.por.fl_str_mv |
Hemodialysis water Endotoxin Microbiological water quality Hemodialysis |
topic |
Hemodialysis water Endotoxin Microbiological water quality Hemodialysis |
description |
Failure on the water treatment poses hemodialysis patients at risk of injury and death. Identifying if the patients are exposed to water quality related microbiological risks is an important objective to reduce the mortality for chronic renal patients and is the main issue of this study. We evaluated the microbiological water quality used by 205 dialysis services in São Paulo State, Brazil between 2010 to 2016. The study included heterotrophic bacteria count, total coliforms research, and bacterial endotoxin determination in 1366 dialysis water samples. The number of unsatisfactory clinics for at least one microbiological parameter decreased 16.0% between 2010 to 2015 but increased 57.2% in 2016. In 2010, the most frequent unsatisfactory parameter was related to heterotrophic bacteria count (54.8%) followed by endotoxin determination (45.2%). However, in 2013 an opposite situation was observed: endotoxin determination as the parameter of the higher incidence of nonconformities. Total coliform was verified at a lower frequency. We highlighted the importance of regular monitoring of dialysis water quality to prevent infections caused by dialytic procedures and to ensure that the water is a safe component of the treatment. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-12-09 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/181572 10.1590/s2175-97902019000417835 |
url |
https://www.revistas.usp.br/bjps/article/view/181572 |
identifier_str_mv |
10.1590/s2175-97902019000417835 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/181572/168564 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2020 Brazilian Journal of Pharmaceutical Sciences http://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2020 Brazilian Journal of Pharmaceutical Sciences http://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
dc.source.none.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences; Vol. 56 (2020); e17835 Brazilian Journal of Pharmaceutical Sciences; v. 56 (2020); e17835 Brazilian Journal of Pharmaceutical Sciences; Vol. 56 (2020); e17835 2175-9790 1984-8250 reponame:Brazilian Journal of Pharmaceutical Sciences instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Brazilian Journal of Pharmaceutical Sciences |
collection |
Brazilian Journal of Pharmaceutical Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
bjps@usp.br||elizabeth.igne@gmail.com |
_version_ |
1800222915101196288 |